SRAIM
NTR icon

Scheer Rowlett & Associates Investment Management’s Nutrien NTR Stock Holding History

Scheer Rowlett & Associates Investment Management’s Portfolio NTR Stock Details NTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.6M Buy
328,425
+40,566
+14% +$2.84M 1.48% 24
2026
Q1 		$21.7M Sell
287,859
-170,672
-37% -$12.2M 1.56% 23
2025
Q4 		$28.3M Sell
458,531
-145,207
-24% -$8.55M 1.94% 20
2025
Q3 		$35.4M Sell
603,738
-10,788
-2% -$629K 2.11% 19
2025
Q2 		$35.8M Buy
614,526
+16,309
+3% +$922K 2.32% 18
2025
Q1 		$29.7M Sell
598,217
-73,772
-11% -$3.77M 2.2% 19
2024
Q4 		$30M Buy
671,989
+69,266
+11% +$3.29M 2.19% 20
2024
Q3 		$29M Sell
602,723
-5,852
-1% -$282K 2.02% 21
2024
Q2 		$31M Sell
608,575
-4,230
-0.7% -$232K 2.37% 19
2024
Q1 		$33.3M Buy
612,805
+85,852
+16% +$4.48M 2.46% 20
2023
Q4 		$29.7M Sell
526,953
-9,749
-2% -$551K 2.24% 20
2023
Q3 		$33.1M Sell
536,702
-9,044
-2% -$572K 2.8% 17
2023
Q2 		$32.2M Buy
545,746
+17,745
+3% +$1.13M 2.58% 18
2023
Q1 		$39M Sell
528,001
-4,031
-0.8% -$311K 3.23% 16
2022
Q4 		$38.8M Sell
532,032
-6,990
-1% -$552K 3.24% 13
2022
Q3 		$44.9M Sell
539,022
-17,329
-3% -$1.49M 4.06% 10
2022
Q2 		$44.3M Sell
556,351
-21,040
-4% -$2.04M 3.51% 11
2022
Q1 		$59.7M Sell
577,391
-319,870
-36% -$26.5M 3.91% 11
2021
Q4 		$67.5M Sell
897,261
-157,960
-15% -$11.1M 4.64% 7
2021
Q3 		$68.4M Buy
1,055,221
+12,134
+1% +$742K 4.86% 7
2021
Q2 		$63.2M Buy
1,043,087
+139,044
+15% +$8.23M 4.57% 8
2021
Q1 		$48.7M Sell
904,043
-45,260
-5% -$2.46M 3.74% 12
2020
Q4 		$45.7M Sell
949,303
-32,610
-3% -$1.44M 3.53% 12
2020
Q3 		$38.5M Sell
981,913
-6,440
-0.7% -$234K 3.39% 15
2020
Q2 		$31.8M Sell
988,353
-17,863
-2% -$622K 2.87% 16
2020
Q1 		$34.4M Sell
1,006,216
-167,630
-14% -$6.71M 3.47% 14
2019
Q4 		$56.3M Buy
1,173,846
+51,380
+5% +$2.48M 4.15% 9
2019
Q3 		$56M Sell
1,122,466
-124,604
-10% -$6.36M 4.32% 8
2019
Q2 		$66.9M Sell
1,247,070
-260,294
-17% -$13.6M 4.58% 7
2019
Q1 		$79.5M Sell
1,507,364
-110,043
-7% -$5.73M 5.55% 6
2018
Q4 		$75.9M Sell
1,617,407
-93,967
-5% -$4.9M 5.85% 6
2018
Q3 		$98.7M Buy
1,711,374
+8,814
+0.5% +$488K 6.29% 6
2018
Q2 		$92.6M Buy
1,702,560
+61,755
+4% +$3.06M 5.79% 6
2018
Q1 		$77.5M Buy
+1,640,805
New +$82.2M 4.95% 6

Other funds holding NTR

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Scheer Rowlett & Associates Investment Management's NTR Position: Q2 2026 in Review

Scheer Rowlett & Associates Investment Management increased its Nutrien (NTR) stake by 14% in Q2 2026, buying an estimated $2.84M and bringing the position to 328,425 shares worth $20.6M. The position accounts for 1.48% of the portfolio, ranked #24.

Scheer Rowlett & Associates Investment Management first reported a position in NTR in Q1 2018 and has held it in 34 quarters since. The position peaked at $98.7M in Q3 2018. 734 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • Scheer Rowlett & Associates Investment Management held 328,425 shares of Nutrien worth $20.6M as of Q2 2026.
  • Scheer Rowlett & Associates Investment Management bought 40,566 Nutrien shares in Q2 2026, an estimated $2.84M.
  • Nutrien made up 1.48% of Scheer Rowlett & Associates Investment Management's portfolio in Q2 2026, its #24 holding.
  • Scheer Rowlett & Associates Investment Management first reported a position in Nutrien in Q1 2018 and has held it in 34 quarters since.
  • Scheer Rowlett & Associates Investment Management's Nutrien position peaked at $98.7M in Q3 2018.
  • 734 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on Scheer Rowlett & Associates Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.